Ventilation strategies in cardiogenic ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Title :
Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry
Author(s) :
Volle, Kim [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Merdji, Hamid [Auteur]
Nanomédecine Régénérative [NanoRegMed]
Les Hôpitaux Universitaires de Strasbourg [HUS]
Bataille, Vincent [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Equipe AGING (CERPOP)
Lamblin, Nicolas [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Université de Lille
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Roubille, François [Auteur]
Centre Hospitalier Régional Universitaire [Montpellier] [CHRU Montpellier]
Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] [PhyMedExp]
Levy, Bruno [Auteur]
Service de Réanimation Médicale [CHRU Nancy]
Champion, Sebastien [Auteur]
Lim, Pascal [Auteur]
Institut Mondor de Recherche Biomédicale [IMRB]
Hôpital Henri Mondor
Schneider, Francis [Auteur]
Biomatériaux et Bioingénierie [BB]
Les Hôpitaux Universitaires de Strasbourg [HUS]
Labbe, Vincent [Auteur]
CHU Tenon [AP-HP]
Khachab, Hadi [Auteur]
Centre Hospitalier d'Aix en Provence [Aix-en-Provence] [CHIAP ]
Bourenne, Jeremy [Auteur]
Aix Marseille Université [AMU]
Hôpital de la Timone [CHU - APHM] [TIMONE]
Seronde, Marie-France [Auteur]
Centre Hospitalier Régional Universitaire de Besançon [CHRU Besançon]
Schurtz, Guillaume [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Harbaoui, Brahim [Auteur]
Hôpital de la Croix-Rousse [CHU - HCL]
Centre de Recherche en Acquisition et Traitement de l'Image pour la Santé [CREATIS]
Vanzetto, Gerald [Auteur]
Centre Hospitalier Universitaire [CHU Grenoble] [CHUGA]
Quentin, Charlotte [Auteur]
CH de Saint-Malo [Broussais]
Combaret, Nicolas [Auteur]
Université Clermont Auvergne [UCA]
CHU Clermont-Ferrand
Marchandot, Benjamin [Auteur]
Université de Strasbourg [UNISTRA]
Nouvel Hôpital Civil de Strasbourg
Lattuca, Benoit [Auteur]
Université de Montpellier [UM]
Hôpital Universitaire Carémeau [Nîmes] [CHU Nîmes]
Biendel, Caroline [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Leurent, Guillaume [Auteur]
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
Laboratoire Traitement du Signal et de l'Image [LTSI]
Bonello, Laurent [Auteur]
Hôpital Nord [CHU - APHM]
Mediterranean Association for Research and Studies in Cardiology [MARS cardio]
Gerbaud, Edouard [Auteur]
Centre de recherche Cardio-Thoracique de Bordeaux [Bordeaux] [CRCTB]
Hôpital Haut-Lévêque [CHU Bordeaux]
Puymirat, Etienne [Auteur]
Université Pierre et Marie Curie - Paris 6 [UPMC]
Hôpital Européen Georges Pompidou [APHP] [HEGP]
Bonnefoy, Eric [Auteur]
Centre Hospitalier Lyon Sud [CHU - HCL] [CHLS]
Aissaoui, Nadia [Auteur]
Université Paris Cité [UPCité]
Hôpital Cochin [AP-HP]
Delmas, Clément [Auteur]
Université Toulouse III - Paul Sabatier [UT3]
Institut des Maladies Métaboliques et Casdiovasculaires [UPS/Inserm U1297 - I2MC]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Merdji, Hamid [Auteur]
Nanomédecine Régénérative [NanoRegMed]
Les Hôpitaux Universitaires de Strasbourg [HUS]
Bataille, Vincent [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Equipe AGING (CERPOP)
Lamblin, Nicolas [Auteur]

Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Université de Lille
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Roubille, François [Auteur]
Centre Hospitalier Régional Universitaire [Montpellier] [CHRU Montpellier]
Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] [PhyMedExp]
Levy, Bruno [Auteur]
Service de Réanimation Médicale [CHRU Nancy]
Champion, Sebastien [Auteur]
Lim, Pascal [Auteur]
Institut Mondor de Recherche Biomédicale [IMRB]
Hôpital Henri Mondor
Schneider, Francis [Auteur]
Biomatériaux et Bioingénierie [BB]
Les Hôpitaux Universitaires de Strasbourg [HUS]
Labbe, Vincent [Auteur]
CHU Tenon [AP-HP]
Khachab, Hadi [Auteur]
Centre Hospitalier d'Aix en Provence [Aix-en-Provence] [CHIAP ]
Bourenne, Jeremy [Auteur]
Aix Marseille Université [AMU]
Hôpital de la Timone [CHU - APHM] [TIMONE]
Seronde, Marie-France [Auteur]
Centre Hospitalier Régional Universitaire de Besançon [CHRU Besançon]
Schurtz, Guillaume [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Harbaoui, Brahim [Auteur]
Hôpital de la Croix-Rousse [CHU - HCL]
Centre de Recherche en Acquisition et Traitement de l'Image pour la Santé [CREATIS]
Vanzetto, Gerald [Auteur]
Centre Hospitalier Universitaire [CHU Grenoble] [CHUGA]
Quentin, Charlotte [Auteur]
CH de Saint-Malo [Broussais]
Combaret, Nicolas [Auteur]
Université Clermont Auvergne [UCA]
CHU Clermont-Ferrand
Marchandot, Benjamin [Auteur]
Université de Strasbourg [UNISTRA]
Nouvel Hôpital Civil de Strasbourg
Lattuca, Benoit [Auteur]
Université de Montpellier [UM]
Hôpital Universitaire Carémeau [Nîmes] [CHU Nîmes]
Biendel, Caroline [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Leurent, Guillaume [Auteur]
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
Laboratoire Traitement du Signal et de l'Image [LTSI]
Bonello, Laurent [Auteur]
Hôpital Nord [CHU - APHM]
Mediterranean Association for Research and Studies in Cardiology [MARS cardio]
Gerbaud, Edouard [Auteur]
Centre de recherche Cardio-Thoracique de Bordeaux [Bordeaux] [CRCTB]
Hôpital Haut-Lévêque [CHU Bordeaux]
Puymirat, Etienne [Auteur]
Université Pierre et Marie Curie - Paris 6 [UPMC]
Hôpital Européen Georges Pompidou [APHP] [HEGP]
Bonnefoy, Eric [Auteur]
Centre Hospitalier Lyon Sud [CHU - HCL] [CHLS]
Aissaoui, Nadia [Auteur]
Université Paris Cité [UPCité]
Hôpital Cochin [AP-HP]
Delmas, Clément [Auteur]
Université Toulouse III - Paul Sabatier [UT3]
Institut des Maladies Métaboliques et Casdiovasculaires [UPS/Inserm U1297 - I2MC]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Journal title :
Clinical Research in Cardiology
Pages :
Online ahead of print
Publisher :
Springer Verlag
Publication date :
2024-10-23
ISSN :
1861-0684
English keyword(s) :
Cardiogenic shock
Mechanical ventilation
Mortality
Non-invasive ventilation
Prognosis
Mechanical ventilation
Mortality
Non-invasive ventilation
Prognosis
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Abstract Background Despite scarce data, invasive mechanical ventilation (MV) is widely suggested as first-line ventilatory support in cardiogenic shock (CS) patients. We assessed the real-life use of different ventilation ...
Show more >Abstract Background Despite scarce data, invasive mechanical ventilation (MV) is widely suggested as first-line ventilatory support in cardiogenic shock (CS) patients. We assessed the real-life use of different ventilation strategies in CS and their influence on short and mid-term prognosis. Methods FRENSHOCK was a prospective registry including 772 CS patients from 49 centers in France. Patients were categorized into three groups according to the ventilatory supports during hospitalization: no mechanical ventilation group (NV), non-invasive ventilation alone group (NIV), and invasive mechanical ventilation group (MV). We compared clinical characteristics, management, and occurrence of death and major adverse event (MAE) (death, heart transplantation or ventricular assist device) at 30 days and 1 year between the three groups. Results Seven hundred sixty-eight patients were included in this analysis. Mean age was 66 years and 71% were men. Among them, 359 did not receive any ventilatory support (46.7%), 118 only NIV (15.4%), and 291 MV (37.9%). MV patients presented more severe CS with more skin mottling, higher lactate levels, and higher use of vasoactive drugs and mechanical circulatory support. MV was associated with higher mortality and MAE at 30 days (HR 1.41 [1.05–1.90] and 1.52 [1.16–1.99] vs NV). No difference in mortality (HR 0.79 [0.49–1.26]) or MAE (HR 0.83 [0.54–1.27]) was found between NIV patients and NV patients. Similar results were found at 1-year follow-up. Conclusions Our study suggests that using NIV is safe in selected patients with less profound CS and no other MV indication. NCT02703038 Graphical abstractShow less >
Show more >Abstract Background Despite scarce data, invasive mechanical ventilation (MV) is widely suggested as first-line ventilatory support in cardiogenic shock (CS) patients. We assessed the real-life use of different ventilation strategies in CS and their influence on short and mid-term prognosis. Methods FRENSHOCK was a prospective registry including 772 CS patients from 49 centers in France. Patients were categorized into three groups according to the ventilatory supports during hospitalization: no mechanical ventilation group (NV), non-invasive ventilation alone group (NIV), and invasive mechanical ventilation group (MV). We compared clinical characteristics, management, and occurrence of death and major adverse event (MAE) (death, heart transplantation or ventricular assist device) at 30 days and 1 year between the three groups. Results Seven hundred sixty-eight patients were included in this analysis. Mean age was 66 years and 71% were men. Among them, 359 did not receive any ventilatory support (46.7%), 118 only NIV (15.4%), and 291 MV (37.9%). MV patients presented more severe CS with more skin mottling, higher lactate levels, and higher use of vasoactive drugs and mechanical circulatory support. MV was associated with higher mortality and MAE at 30 days (HR 1.41 [1.05–1.90] and 1.52 [1.16–1.99] vs NV). No difference in mortality (HR 0.79 [0.49–1.26]) or MAE (HR 0.83 [0.54–1.27]) was found between NIV patients and NV patients. Similar results were found at 1-year follow-up. Conclusions Our study suggests that using NIV is safe in selected patients with less profound CS and no other MV indication. NCT02703038 Graphical abstractShow less >
Language :
Anglais
Peer reviewed article :
Oui
Audience :
Internationale
Popular science :
Non
Collections :
Source :
Files
- document
- Open access
- Access the document
- 2024%20Volle%20et%20al%20Ventilation.pdf
- Open access
- Access the document